Hiroaki Mamiya

Associate Professor

International University of Health and Welfare

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hiroaki Mamiya is an Associate Professor at the International University of Health and Welfare in Japan. His research focuses on health economics, including the prescription trends of biosimilars, the implications of reimbursement policies, and the characteristics of clinical trials for drug approval. Recent articles authored by Professor Mamiya examine the impact of drug pricing and market dynamics within Japan's national health insurance system.

Articles (7)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Collaborators (2)

Toshiki Fukasawa

Program-specific Assistant Professor

Kyoto University

JAPAN

View details

ataru igarashi

Associate Professor

University of Tokyo

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hiroaki Mamiya

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Effects of Reimbursement Add-On Policies on Trastuzumab and Bevacizumab Biosimilar Adoption in a Japanese Oncology Setting

Temporal Trends in the Prescription of Biosimilars and the Status of Switching from Original Biologics to Biosimilars at Individual and Institutional Levels in Japan

Including Productivity as an Element to Reflect Value of the Treatment: A Systematic Review of Published Health Economic Evaluations

Draft Guideline for Industry to Manage Drug Shortages in Japan

Characteristics of Clinical Trials for the US Food and Drug Administration Accelerated Approval and Subsequent Confirmatory Trials: Implications for Drug Approval in Japan

Impact of reimbursement restriction on drug market sales under the National Health Insurance in Japan

Determinants of market prices for drugs under Japan’s national health insurance

Collaborators (2)

Toshiki Fukasawa

ataru igarashi

Make your next move.